loadpatents
name:-0.013005971908569
name:-0.0075838565826416
name:-0.0036740303039551
Nikoulin; Igor Patent Filings

Nikoulin; Igor

Patent Applications and Registrations

Patent applications and USPTO patent grants for Nikoulin; Igor.The latest application filed is for "liposomal anticancer compositions".

Company Profile
3.6.13
  • Nikoulin; Igor - San Diego CA
  • Nikoulin; Igor - La Jolla CA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Liposomal Anticancer Compositions
App 20210205245 - Nikoulin; Igor ;   et al.
2021-07-08
Liposomal anticancer compositions
Grant 11,033,520 - Nikoulin , et al. June 15, 2
2021-06-15
Solubilization of pterostilbene and resveratrol for aqueous beverages
Grant 10,703,699 - McChesney , et al.
2020-07-07
Lipsomal Anticancer Compositions
App 20190269635 - Nikoulin; Igor
2019-09-05
Nanoparticulate compositions for targeted delivery of acid labile, lipophilic prodrugs of cancer chemotherapeutics and their preparation
Grant 10,369,105 - McChesney , et al.
2019-08-06
Nanoparticulate compositions for targeted delivery of acid labile, lipophilic prodrugs of cancer chemotherapeutics and their preparation
Grant 10,064,823 - McChesney , et al. September 4, 2
2018-09-04
Nanoparticulate Compositions for Targeted Delivery of Acid Labile, Lipophilic Prodrugs of Cancer Chemotherapeutics and Their Preparation
App 20180235883 - McChesney; James D. ;   et al.
2018-08-23
Solubilization Of Pterostilbene And Resveratrol For Aqueous Beverages
App 20180127344 - McChesney; James D. ;   et al.
2018-05-10
Solubilization of pterostilbene and resveratrol in aqueous beverages
Grant 9,896,403 - McChesney , et al. February 20, 2
2018-02-20
Nanoparticulate Compositions for Targeted Delivery of Acid Labile, Lipophilic Prodrugs of Cancer Chemotherapeutics and Their Preparation
App 20170042815 - McChesney; James D. ;   et al.
2017-02-16
Nanoparticulate compositions for targeted delivery of acid labile, lipophilic prodrugs of cancer chemotherapeutics and their preparation
Grant 9,468,603 - McChesney , et al. October 18, 2
2016-10-18
Solubilization of Pterostilbene and Resveratrol in Aqueous Beverages
App 20160052850 - McChesney; James D. ;   et al.
2016-02-25
Nanoparticulate Compositions for Targeted Delivery of Acid Labile, Lipophilic Prodrugs of Cancer Chemotherapeutics and Their Preparation
App 20150079189 - McChesney; James D. ;   et al.
2015-03-19
Mediators of reverse cholesterol transport for the treatment of hypercholesterolemia
App 20070004644 - Sircar; Jagadish C. ;   et al.
2007-01-04
Mediators of reverse cholesterol transport for the treatment of hypercholesterolemia
App 20060166891 - Sircar; Jagadish C. ;   et al.
2006-07-27
Heterocyclic derivatives for treatment of hyperlipidemia and related diseases
App 20060009487 - Sircar; Jagadish C. ;   et al.
2006-01-12
Small molecules for treatment of hypercholesterolemia and related diseases
App 20050277690 - Sircar, Jagadish C. ;   et al.
2005-12-15
Mediators of reverse cholesterol transport for the treatment of hypercholesterolemia
App 20050159362 - Sircar, Jagadish C. ;   et al.
2005-07-21

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed